Literature DB >> 2847282

Interactions of cytomegalovirus with the human immune system.

A H Rook1.   

Abstract

Infection of the normal host with human cytomegalovirus (HCMV) is followed by both humoral and cellular immune responses against this herpesvirus. The importance of cell-mediated immunity against HCMV is exemplified by the occurrence of severe and prolonged HCMV infections in individuals with congenital, iatrogenic, or acquired deficiencies of this arm of host immunity. In contrast, infection in most individuals with primary B cell disorders usually is not severe. The nature of different aspects of cell-mediated immunity, including cytotoxic T cell (CTL) responses and levels of natural killer cell (NKC) and antibody-dependent cellular cytotoxicity (ADCC) during infection, has been characterized in detail in susceptible populations. To a high degree, the presence or absence of CMV-specific CTL responses correlates inversely with the severity of infection, as do levels of NKC and ADCC activity. Clinical correlates of these immune responses will be discussed. In addition, recent observations implicating HCMV as an immunosuppressive virus will be presented.

Entities:  

Mesh:

Year:  1988        PMID: 2847282     DOI: 10.1093/clinids/10.supplement_3.s460

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150.

Authors:  Xuekui Yu; Jonathan Jih; Jiansen Jiang; Z Hong Zhou
Journal:  Science       Date:  2017-06-30       Impact factor: 47.728

3.  Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Authors:  Heinrich Schlums; Frank Cichocki; Bianca Tesi; Jakob Theorell; Vivien Beziat; Tim D Holmes; Hongya Han; Samuel C C Chiang; Bree Foley; Kristin Mattsson; Stella Larsson; Marie Schaffer; Karl-Johan Malmberg; Hans-Gustaf Ljunggren; Jeffrey S Miller; Yenan T Bryceson
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

4.  Incidence of CMV-HCV coinfection in renal transplant recipient.

Authors:  Avirup Chakraborty; Krishna Patil; Sanjay Dasgupta; Abhijit Tarafdar; Sekhar Chakrabarti; Nilanjan Chakraborty
Journal:  BMJ Case Rep       Date:  2012-04-02

5.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 6.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

7.  Replication of human cytomegalovirus in the cells of the U937 monocytoid cell line.

Authors:  K Numazaki; N Nagata; T Sato; S Chiba
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 8.  Cytomegalovirus infection and disease after liver transplantation. An overview.

Authors:  R J Stratta; M S Shaeffer; R S Markin; R P Wood; A N Langnas; E C Reed; J P Donovan; G L Woods; K A Bradshaw; T J Pillen
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 9.  Cytomegalovirus prostatitis. Case report and review of the literature.

Authors:  T C McKay; D M Albala; K Sendelbach; P Gattuso
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 10.  Cell-mediated immunity to human CMV infection: a brief overview.

Authors:  Nadia Terrazzini; Florian Kern
Journal:  F1000Prime Rep       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.